23andMe to sell DNA records to drug company | Boing Boing - 0 views
-
dr tech on 31 Oct 23"Have you been looking forward to somniferous alkaloid compounds customized to your personal metabolic dependency profile? Good news! 23andMe is selling everyone's DNA to the pharmaceutical industry. GSK Plc will pay 23andMe Holding Co. $20 million for access to the genetic-testing company's vast trove of consumer DNA data, extending a five-year collaboration that's allowed the drugmaker to mine genetic data as it researches new medications."